| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $96K | -91.6% |
| SG&A Expense | $274K | -31.3% |
| Pre-tax Income | -$591K | +64.2% |
| Income Tax | $0 | — |
| Net Income | -$591K | +64.2% |
| EPS (Basic) | -$0.01 | +50.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157K | -77.2% |
| Total Assets | $184K | -74.4% |
| Current Liabilities | $274K | -9.5% |
| Stockholders' Equity | -$90K | -121.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$533K | +64.1% |